title: The effects of fructose intake on serum uric acid vary among controlled dietary trials.
abstract: Hyperuricemia is linked to gout and features of metabolic syndrome. There is concern that dietary fructose may increase uric acid concentrations. To assess the effects of fructose on serum uric acid concentrations in people with and without diabetes, we conducted a systematic review and meta-analysis of controlled feeding trials. We searched MEDLINE, EMBASE, and the Cochrane Library for relevant trials (through August 19, 2011). Analyses included all controlled feeding trials ≥ 7 d investigating the effect of fructose feeding on uric acid under isocaloric conditions, where fructose was isocalorically exchanged with other carbohydrate, or hypercaloric conditions, and where a control diet was supplemented with excess energy from fructose. Data were aggregated by the generic inverse variance method using random effects models and expressed as mean difference (MD) with 95% CI. Heterogeneity was assessed by the Q statistic and quantified by I(2). A total of 21 trials in 425 participants met the eligibility criteria. Isocaloric exchange of fructose for other carbohydrate did not affect serum uric acid in diabetic and nondiabetic participants [MD = 0.56 μmol/L (95% CI: -6.62, 7.74)], with no evidence of inter-study heterogeneity. Hypercaloric supplementation of control diets with fructose (+35% excess energy) at extreme doses (213-219 g/d) significantly increased serum uric acid compared with the control diets alone in nondiabetic participants [MD = 31.0 mmol/L (95% CI: 15.4, 46.5)] with no evidence of heterogeneity. Confounding from excess energy cannot be ruled out in the hypercaloric trials. These analyses do not support a uric acid-increasing effect of isocaloric fructose intake in nondiabetic and diabetic participants. Hypercaloric fructose intake may, however, increase uric acid concentrations. The effect of the interaction of energy and fructose remains unclear. Larger, well-designed trials of fructose feeding at "real world" doses are needed.
authors.affiliation: Clinical Nutrition and Risk Factor Modification Centre, St. Michael’s Hospital, Toronto, ON, Canada.
authors.forename: D David
authors.initials: DD
authors.lastname: Wang
authors.forename: John L
authors.initials: JL
authors.lastname: Sievenpiper
authors.forename: Russell J
authors.initials: RJ
authors.lastname: de Souza
authors.forename: Laura
authors.initials: L
authors.lastname: Chiavaroli
authors.forename: Vanessa
authors.initials: V
authors.lastname: Ha
authors.forename: Adrian I
authors.initials: AI
authors.lastname: Cozma
authors.forename: Arash
authors.initials: A
authors.lastname: Mirrahimi
authors.forename: Matthew E
authors.initials: ME
authors.lastname: Yu
authors.forename: Amanda J
authors.initials: AJ
authors.lastname: Carleton
authors.forename: Marco
authors.initials: M
authors.lastname: Di Buono
authors.forename: Alexandra L
authors.initials: AL
authors.lastname: Jenkins
authors.forename: Lawrence A
authors.initials: LA
authors.lastname: Leiter
authors.forename: Thomas M S
authors.initials: TM
authors.lastname: Wolever
authors.forename: Joseph
authors.initials: J
authors.lastname: Beyene
authors.forename: Cyril W C
authors.initials: CW
authors.lastname: Kendall
authors.forename: David J A
authors.initials: DJ
authors.lastname: Jenkins
mesh_terms: D002986:Clinical Trials as Topic; D003927:Diet, Diabetic / Q000379:methods*; D004734:Energy Metabolism / Q000502:physiology; D005632:Fructose / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D033461:Hyperuricemia / Q000378:metabolism*; D024821:Metabolic Syndrome / Q000378:metabolism*; D014527:Uric Acid / Q000097:blood*
chemical_list: D014527:Uric Acid; D005632:Fructose